商品詳細

This book offers a comprehensive overview of the rapidly evolving fields of pharmacoproteomics and microbiome science, and their synergistic role in shaping the future of precision medicine. Written by leading experts, it explores how proteomic profiles and microbial communities interact to influence drug metabolism, therapeutic efficacy, and disease progression. The first section explains the principles of pharmacoproteomics and microbiome biology, followed by detailed discussions on molecular interactions and crosstalk between host proteins and microbial ecosystems. Subsequent sections delve into cutting-edge analytical platforms, including mass spectrometry-based proteomics, metaproteomics, and AI-driven multi-omics integration, highlighting their application in biomarker discovery and drug response prediction. The clinical chapters provide disease-specific insights into how these interactions impact neurological disorders, autoimmune conditions, infectious diseases, oncology, and cardiometabolic health. The book is rounded out with a discussion of ethical and regulatory considerations, translational challenges, and future directions for the next generation of personalized therapeutics.